Continue to Site

Medtronic appoints Pfizer EVP as independent board director

By Sean Whooley | June 27, 2022

Portrait photo of Pfizer EVP and Medtronic board member Lidia Fonseca

Lidia Fonseca is EVP and chief digital and technology officer at Pfizer [Image courtesy of Fonseca]

Medtronic (NYSE:MDT) announced today that it appointed Lidia Fonseca to its board of directors as an independent director.

Fonseca, who serves as EVP and chief digital and technology officer at Pfizer, will become a director effective today. She will serve on the board’s Compensation Committee and Science and Technology Committee.

Get the full story on our sister site MassDevice.

Filed Under: Drug Discovery
Tagged With: Medtronic, Personnel Moves, Pfizer

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.